Trial Profile
Head to head comparison of Myfortic [mycophenolate sodium] vs. Cellcept [mycophenolate mofetil] in the treatment of kidney transplant recipients using our current center standardized concomitant immunosuppressive protocol
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Oct 2023
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 06 Oct 2007 New trial record.